Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Type of drug preparation | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Solid dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Has state of matter (attribute) | Solid (state of matter) | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Verapamil hydrochloride 240 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely hydroxyzine pamoate 25 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Amoxicillin 875 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely prochlorperazine maleate 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely venlafaxine hydrochloride 25 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely venlafaxine hydrochloride 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Rosiglitazone maleate 2mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Paroxetine hydrochloride 10mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Paroxetine hydrochloride 40mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Perindopril erbumine 8 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely lithium carbonate 300 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Hydromorphone hydrochloride 3 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sertraline hydrochloride 25mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Oxycodone hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Oxycodone hydrochloride 15 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Oxycodone hydrochloride 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Molindone hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Molindone hydrochloride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Molindone hydrochloride 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Molindone hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely molindone hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Warfarin sodium 4 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely warfarin sodium 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Warfarin sodium 7.5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Warfarin sodium 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Warfarin sodium 2.5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Warfarin sodium 6 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Amlodipine besylate 2.5mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Tiagabine hydrochloride 4 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Tiagabine hydrochloride 12 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Tiagabine hydrochloride 16 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Benazepril hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Benazepril hydrochloride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Benazepril hydrochloride 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Albuterol sulfate 4mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin ultramicrosize 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin microsize 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nefazodone hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Nefazodone hydrochloride 150 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely nefazodone hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Buspirone hydrochloride 15mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing buspirone hydrochloride dividose 30 mg/1 each oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely fexofenadine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely cefuroxime axetil 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cefaclor 500mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isradipine 5mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isradipine 10mg controlled release tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ondansetron hydrochloride 24 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Cefuroxime axetil 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely cefuroxime axetil 601.44 milligram/1 each conventional release oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Candesartan cilexetil 32 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Magnesium salicylate 600 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Meclozine hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Erythromycin estolate 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Chloroquine phosphate 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Oxybutynin hydrochloride 15mg m/r tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Quinidine gluconate 324mg m/r tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin ultramicrosize 165 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Griseofulvin ultramicrosize 330 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Midodrine hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Meclozine hydrochloride 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Theophylline anhydrous 450mg m/r tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Tiagabine hydrochloride 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Alendronate sodium 13.05mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Disopyramide phosphate 100mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ropinirole hydrochloride 500micrograms tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ropinirole hydrochloride 3mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isosorbide mononitrate 30mg tablet (product) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Propafenone hydrochloride 225 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Fosinopril sodium 40 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Metformin hydrochloride 1 g oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely fluvoxamine maleate 25 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Diltiazem hydrochloride 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sotalol hydrochloride 120 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Sotalol hydrochloride 240 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Desmopressin acetate 0.2mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Desmopressin acetate 0.1mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Verapamil hydrochloride 180mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Verapamil hydrochloride 400mg tablet (product) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Promethazine hydrochloride 12.5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Promethazine hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely tocainide hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Clonidine hydrochloride 0.2mg tablet (product) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ranitidine hydrochloride 150mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Ranitidine hydrochloride 300mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Terbutaline sulfate 2.5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Desipramine hydrochloride 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely desipramine hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Desipramine hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Desipramine hydrochloride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Bethanechol chloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Bethanechol chloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Imipramine hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Isoxsuprine hydrochloride 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing precisely isoxsuprine hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Amfepramone hydrochloride 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Existential restriction modifier (core metadata concept) |
Start Previous Page 20 of 28 Next End
This concept is not in any reference sets